Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;19(1):80-95.
doi: 10.4162/nrp.2025.19.1.80. Epub 2025 Jan 15.

Dietary isoflavone intake among breast cancer survivors and cancer-free women

Affiliations

Dietary isoflavone intake among breast cancer survivors and cancer-free women

Sihan Song et al. Nutr Res Pract. 2025 Feb.

Abstract

Background/objectives: Isoflavones are estrogen-like compounds found in plants and their health effects remain equivocal. We investigated dietary isoflavone intake and its associated factors in Korean breast cancer survivors, with a comparison to cancer-free women.

Subjects/methods: The usual dietary intake of breast cancer survivors (n = 981, mean age 52 yrs) in 9 hospitals between 2012 and 2019 was assessed using 3-day food records or food frequency questionnaires (FFQs). They were age-matched to 2,943 cancer-free women who completed FFQs as part of a nationwide study conducted between 2012 and 2016. We used the flavonoid database of common Korean foods and the Phenol-Explorer database to estimate isoflavone intake. The contribution of each food or food group to the total isoflavone intake was calculated. The adjusted least-squares means of dietary isoflavone intake according to lifestyle and clinical factors were calculated using generalized linear models.

Results: Breast cancer survivors had a higher mean dietary isoflavone intake (23.59 mg/day) than cancer-free women (17.81 mg/day). Major food sources, including tofu, soybeans, and doenjang, contributed to over 70% of the isoflavone intake in both groups. When we estimated dietary isoflavone intake according to lifestyle characteristics, isoflavone intake increased with higher scores of adherence to the American Cancer Society dietary guidelines but decreased with increasing body mass index in both groups. Among cancer-free women, dietary isoflavone intake was higher among those who had never smoked and among dietary supplement users. Among breast cancer survivors, dietary isoflavone intakes did not vary with clinical characteristics, including time since surgery and estrogen receptor status.

Conclusion: Breast cancer survivors were more likely to consume isoflavones than age-matched cancer-free women. Dietary isoflavone intake was associated with healthy lifestyle characteristics in women both with and without breast cancer. Further research is needed to understand the role of the higher isoflavone intake among breast cancer survivors compared to cancer-free women on their prognosis.

Keywords: Isoflavones; breast cancer; soy foods.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors declare no potential conflicts of interests.

Figures

Fig. 1
Fig. 1. Flowchart of the study population. For each breast cancer survivor, 3 cancer-free women were randomly age-matched.
3-DFRs, 3-day food records; FFQs, food frequency questionnaires; KNHANES, Korea National Health and Nutrition Examination Survey.

References

    1. Dixon RA. Phytoestrogens. Annu Rev Plant Biol. 2004;55:225–261. - PubMed
    1. Setchell KDR. The history and basic science development of soy isoflavones. Menopause. 2017;24:1338–1350. - PubMed
    1. Palacios S. In: Postmenopausal Diseases and Disorders. Pérez-López FR, editor. Cham: Springer International Publishing; 2019. Selective estrogen receptor modulators (SERMs): state of the art; pp. 349–366.
    1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–263. - PubMed
    1. Rojas K, Stuckey A. Breast cancer epidemiology and risk factors. Clin Obstet Gynecol. 2016;59:651–672. - PubMed